News Conference News ACC 2021 Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia Yael L. Maxwell May 16, 2021
News Daily News Gatekeeper CTA Strategy in Stable Chest Pain Still Needs Honing Yael L. Maxwell March 08, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020
News Daily News Inclisiran Approved in Europe for Lowering LDL Cholesterol Michael O'Riordan December 11, 2020
News Conference News AHA 2020 Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON Michael O'Riordan November 15, 2020
News Conference News AHA 2020 Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol Michael O'Riordan November 12, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News EAS 2020 Just One-Third of European Patients Get to LDL Cholesterol Goals Michael O'Riordan October 13, 2020
News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Conference News EAS 2020 Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank Michael O'Riordan October 07, 2020
News Daily News More Insights Into AAA Genetics Spur New Questions on Screening Caitlin E. Cox September 29, 2020
News Daily News LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes Yael L. Maxwell September 14, 2020
News Conference News ESC 2020 In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD Yael L. Maxwell September 01, 2020
News Daily News Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated Yael L. Maxwell August 27, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News PAD Patients Undertreated With Statins Despite Elevated CV Risk L.A. McKeown July 13, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020